NOVC - Novation Companies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0580
+0.0129 (+28.60%)
At close: 12:05PM EST
Stock chart is not supported by your current browser
Previous Close0.0451
Open0.0517
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0497 - 0.0580
52 Week Range0.0100 - 0.1000
Volume13,796
Avg. Volume77,916
Market Cap6.519M
Beta (5Y Monthly)0.92
PE Ratio (TTM)N/A
EPS (TTM)-0.0220
Earnings DateMar 29, 2020 - Apr 08, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 13, 2006
1y Target Est7.50
  • GlobeNewswire

    Novation Companies Announces Date of 2019 Annual Meeting of Shareholders

    Novation Companies, Inc. (NOVC) (“Novation” or the “Company”), which through its subsidiary Healthcare Staffing, Inc. provides outsourced health care staffing and related services in the State of Georgia, is announcing that its 2019 Annual Meeting of Shareholders (the “2019 Annual Meeting”) will be held on December 12, 2019, at 10:00 a.m. Central Standard Time in Kansas City.  Shareholders of record of Novation common stock at the close of business on October 24, 2019, the record date for the 2019 Annual Meeting, will be entitled to notice of, and to vote at, the 2019 Annual Meeting. Shareholder proposals intended to be presented at the 2019 Annual Meeting pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended, must be received by the Company not later than 5:00 p.m. Central Standard Time on October 25, 2019, in order to be considered for inclusion in the Company’s proxy statement for the 2019 Annual Meeting.  For a shareholder to bring business before the 2019 Annual Meeting outside of Rule 14a-8 or to nominate a director, it must provide timely written notice to the Company in accordance with the advance notice provisions of the Company’s Second Amended and Restated Bylaws.

  • Moody's

    TABERNA PREFERRED FUNDING II, LTD. -- Moody's: Taberna Preferred Funding II, Ltd. ratings unaffected by Amendment to Novation Companies Inc. Underlying Instrument

    Moody's Investor Service has determined that certain amendments (the "Amendments") to an underlying instrument issued by Novation Companies Inc. (the "Company") and held as collateral by Taberna Preferred Funding II, Ltd. (the "Issuer") will not at this time in and of itself result in the withdrawal, reduction or other adverse action to Moody's current ratings of any class of Notes issued by the Issuer. The principal methodology used in these ratings was "Moody's Approach to Rating TruPS CDOs" published in March 2019. Moody's will continue monitoring the ratings.